B. Riley Wealth Management’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

B. Riley Wealth Management’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-3,904	Closed	-$441K	–	140
2015 Q4	$441K	Sell	3,904 -3,029	-44%	-$326K	0.56%	56
2015 Q3	$702K	Buy	6,933 +4,874	+237%	+$580K	1%	23
2015 Q2	$255K	Sell	2,059 -1,884	-48%	-$227K	0.2%	142
2015 Q1	$466K	Buy	3,943 +2,525	+178%	+$285K	0.35%	65
2014 Q4	$144K	Buy	1,418 +1,083	+323%	+$106K	0.12%	208
2014 Q3	$30K	Sell	335 -220	-40%	-$19.1K	0.02%	516
2014 Q2	$45K	Buy	555 +320	+136%	+$24.5K	0.03%	480
2014 Q1	$18K	Buy	+235	New	+$18.3K	0.01%	652

Other funds holding FBT

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

B. Riley Wealth Management's FBT Position: Q1 2016 in Review

B. Riley Wealth Management sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q1 2016, closing a stake of 3,904 shares — an estimated $441K sold.

B. Riley Wealth Management first reported a position in FBT in Q1 2014 and held it in 8 quarters. The position peaked at $702K in Q3 2015. 107 funds tracked by Wall St. Rank hold FBT as of Q1 2016.

B. Riley Wealth Management reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q1 2016 after selling out during the quarter.
B. Riley Wealth Management sold 3,904 First Trust NYSE Arca Biotechnology Index Fund shares in Q1 2016, an estimated $441K.
B. Riley Wealth Management first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q1 2014 and held it in 8 quarters.
B. Riley Wealth Management's First Trust NYSE Arca Biotechnology Index Fund position peaked at $702K in Q3 2015.
107 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q1 2016.

Based on B. Riley Wealth Management's 13F filing for Q1 2016, filed 12 Apr 2016.